Skip to main content Accessibility help

D1 and D2 and D3

  • D. Healy (a1)


Good scientific hypotheses rarely succumb to a lack of confirmatory evidence; they may sometimes even be resistant to apparent outright refutation (Kuhn, 1970; Lakatos, 1970). Considering this, Kuhn (1970) suggested that the dominant hypotheses in a field are often replaced not on grounds of greater theoretical coherence but rather on grounds of strategic necessity.



Hide All
American Psychiatric Association (1980) Diagnostic and Statistical Manual of Mental Disorders (3rd edn) (DSM—III). Washington, DC: APA.
Anden, N. E., Butcher, S. G., Corrodi, H., et al (1970) Receptor activity and turnover of dopamine and noradrenaline after neuroleptics. European Journal of Pharmacology, 11, 303.
Bannon, M. J. & Roth, R. H. (1983) Pharmacology of mesocortical dopamine neurones. Pharmacological Reviews, 35, 5368.
Baldessarini, R. (1980) Drugs used in the treatment of the psychoses. In The Pharmacological Basis of Therapeutics (6th edn) (eds Gilman, A. G., Goodman, L. S. & Gilman, A.), pp. 395418. Basingstoke: MacMillan.
Bellack, A. S., Mueser, K. T., Morrison, R. L., et al (1990) Remediation of cognitive deficits in schizophrenia. American Journal of Psychiatry, 147, 16501655.
Berger, H. J., van Hoof, J. J., van Spaendonck, K. P., et al (1989) Haloperidol and cognitive shifting. Neuropsychology, 27, 629639.
Bowers, M. B. (1985) Cerebrospinal fluid homovanillic acid and hypokinetic effects of neuroleptics. Psychopharmacology, 15, 184186.
Bowers, M. B. & Heninger, G. R. (1981) Cerebrospinal fluid homovanillic acid patterns during neuroleptic treatment. Psychiatry Research, 4, 285290.
Bowers, M. B. & Swigar, M. E. (1988) Psychotic patients who become worse on neuroleptics. Journal of Clinical Psychopharmacology, 8, 417421.
Carmen, E. H., Rieker, P. P. & Mills, T. (1984) Victims of violence and psychiatric illness. American Journal of Psychiatry, 141, 378383.
Carlsson, A. (1990) Early psychopharmacology and the rise of modem brain research. Journal of Psychopharmacology, 4, 120126.
Carlsson, A. & Lindquist, M. (1963) Effect of chlorpromazine and haloperidol on formation of 3-methoxy-tyramine and normetanephrine in mouse brain. Acta Pharmacologia et Toxicologia, 20, 140144.
Cassens, G., Inglis, A. K., Appelbaum, P. S., et al (1990) Neuroleptics; effects on neuropsychological function in chronic schizophrenic patients. Schizophrenia Bulletin, 16, 477499.
Chadwick, P. J. & Lowe, F. (1990) Measurement and modification of delusional beliefs. British Journal of Clinical Psychology, 26, 257265.
Chapman, J. (1966) The early symptoms of schizophrenia. British Journal of Psychiatry, 112, 225251.
Chapman, J. (1967) Visual imagery and motor phenomena in acute schizophrenia. British Journal of Psychiatry, 113, 771778.
Chapman, J. & McGhie, A. (1963) An approach to the psychotherapy of cognitive dysfunction in schizophrenia. British Journal of Medical Psychology, 36, 253260.
Chapman, J. & McGhie, A. (1964) Echopraxia in schizophrenia. British Journal of Psychiatry, 110, 365374.
Chu, J. A. & Dill, D. L. (1990) Dissociative symptoms in relation to childhood physical and sexual abuse. American Journal of Psychiatry, 147, 887892.
Cohen, R. M., Semple, W. E., Gross, M., et al (1987) Dysfunction in a prefrontal substrate of sustained attention in schizophrenia. Life Sciences, 40, 20312039.
Cooper, J. E., Kendell, R. E., Gurland, B. J., et al (1972) Psychiatric Diagnosis in New York and London: A Comparative Study of Mental Hospital Admissions. Oxford: Oxford University Press.
Crow, T. J. (1980) Positive and negative schizophrenic symptoms and the role of dopamine. British Journal of Psychiatry, 137, 383386.
Crow, T. J. (1990) Temporal lobe asymmetries as the key to the etiology of schizophrenia. Schizophrenia Bulletin, 16, 433444.
Falloon, I. R. & Talbot, R. E. (1981) Persistent auditory hallucinations: coping mechanisms and implications for management. Psychological Medicine, 11, 329339.
Farde, L., Wiesel, F.-A., Hall, H., et al (1987) No D-2 receptor increase in PET study of schizophrenia. Archives of General Psychiatry, 44, 671672.
Farde, L., Wiesel, F.-A., Stone-Elander, S., et al (1990) D-2 dopamine receptors in neuroleptic naive schizophrenic patients. Archives of General Psychiatry, 47, 213219.
Frith, C. D. (1987) The positive and negative symptoms of schizophrenia reflect impairments in the perception and initiation of action. Psychological Medicine, 17, 631648.
Frith, C. D. & Done, D. J. (1988) Towards a neuropsychology of schizophrenia. British Journal of Psychiatry, 153, 437443.
Glennon, R. A. (1990) Serotonin receptors: clinical implications. Neuroscience and Biobehavioural Reviews, 14, 3547.
Goldberg, T. E., Weinberger, D. R., Berman, K. F., et al (1987) Further evidence for dementia of the prefrontal type in schizophrenia. Archives of General Psychiatry, 44, 10081014.
Healy, D. (1987) The structure of psychopharmacological revolutions. Psychiatry Developments, 4, 349376.
Healy, D. (1989) Neuroleptics and psychic indifference. Journal of the Royal Society of Medicine, 82, 615619.
Healy, D. (1990a) Schizophrenia: basic, release, reactive and defect processes. Human Psychopharmacology, 5, 105121.
Healy, D. (1990b) The Suspended Revolution: Psychiatry and Psychotherapy Re-examined. London: Faber & Faber.
Healy, D. (1991) Images of Uncertainty: Trauma, Neurosis, Hysteria. London: Faber & Faber.
Herman, J. L., Perry, C., Van der Kolk, B. A. (1989) Childhood trauma in borderline personality disorder. American Journal of Psychiatry, 146, 490495.
Joseph, M. H., Frith, C. D. & Waddington, J. L. (1979) Dopaminergic mechanisms and cognitive deficits in schizophrenia. Psychopharmacology, 63, 273280.
King, D. J. (1990) The effect of neuroleptics on cognitive and psychomotor function. British Journal of Psychiatry, 157, 799811.
Kluft, R. P. (1987) First-rank symptoms as a diagnostic clue to multiple personality disorder. American Journal of Psychiatry, 144, 293298.
Koehler, K. (1979) First rank symptoms of schizophrenia; questions concerning clinical boundaries. British Journal of Psychiatry, 134, 236248.
Kroll, J. (1988) The Challenge of the Borderline Patient. New York: Norton.
Kuhn, T. (1970) The Structure of Scientific Revolutions. Chicago: University of Chicago Press.
Lakatos, I. (1970) Falsification and the methodology of scientific research programmes. In Criticism and the Growth of Knowledge (eds Lakatos, I. & Musgrove, A.). Cambridge: Cambridge University Press.
Lowe, F. & Chadwick, P. J. (1990) Verbal control of delusions. Behaviour Therapy, 21, 461480.
May, P. R., Van Putten, T., Yale, C., et al (1976) Predicting individual responses to drug treatment in schizophrenia: a test dose model. Journal of Nervous and Mental Diseases, 162, 177183.
McKenna, P. J. (1987) Pathology, phenomenology and the dopamine hypothesis of schizophrenia. British Journal of Psychiatry, 151, 288301.
McGhie, A. & Chapman, J. (1961) Disorders of attention and perception in early schizophrenia. British Journal of Medical Psychology, 34, 103116.
Medalia, A., Gold, J. & Merriam, A. (1988) The effects of neuroleptics on neuropsychological test results of schizophrenics. Archives of Clinical Neuropsychology, 3, 249271.
Mesulam, M. M. (1981) Dissociative states with abnormal temporal lobe EEG: multiple personality and the illusion of possession. Archives of Neurology, 38, 176181.
Montgomery, S. A. & Montgomery, D. (1982) Pharmacological prevention of suicidal behaviour. Journal of Affective Disorders, 4, 291298.
Robbins, T. W. (1990) The case for frontostriatal dysfunction in schizophrenia. Schizophrenia Bulletin, 16, 391401.
Roberts, G. W. (1991) Schizophrenia: a neuropathological perspective. British Journal of Psychiatry, 158, 817.
Ross, C. A., Miller, S. D., Reagor, P., et al (1990) Schneiderian symptoms in multiple personality disorder and schizophrenia. Comprehensive Psychiatry, 31, 111118.
Seeman, P. (1980) Brain dopamine receptors. Pharmacology Review, 32, 229313.
Silverstone, T. (1985) Dopamine in manic-depressive illness. Journal of Affective Disorders, 8, 225231.
Snyder, S. H. (1976) The dopamine hypothesis of schizophrenia; focus on the dopamine receptor. American Journal of Psychiatry, 133, 197202.
Snyder, S. H. (1982) Schizophrenia. Lancet, ii, 970973.
Sokoloff, P., Giros, B., Martres, M.-P., et al (1990) Molecular cloning and characterisation of a novel dopamine receptor (D-3) as a target for neuroleptics. Nature, 347, 146151.
Spohn, H. E. & Strauss, M. E. (1989) Relation of neuroleptic and anticholinergic medication to cognitive functions in schizophrenia. Journal of Abnormal Psychology, 98, 367380.
Stevens, J. R. (1973) An anatomy of schizophrenia. Archives of General Psychiatry, 29, 177189.
Swazey, J. P. (1974) Chlorpromazine in Psychiatry. Cambridge, Mass.: MIT Press.
Taylor, M. A. & Abrams, R. (1978) The prevalence of schizophrenia: a reassessment using modern criteria. American Journal of Psychiatry, 135, 945948.
Trimble, M. R. (1990) First-rank symptoms of Schneider: a new perspective? British Journal of Psychiatry, 156, 195200.
Van Putten, T., Mutalipassi, L. R., Malkin, M. D., et al (1974) Phenothiazine-induced decompensation. Archives of General Psychiatry, 30, 102105.
Van Putten, T., May, P. R., Marder, S. R., et al (1981) Subjective response to antipsychotic drugs. Archives of General Psychiatry, 38, 187190.
Van Putten, T., Marder, S. R. & Mintz, J. (1990) A controlled dose comparison of haloperidol in newly admitted schizophrenic patients. Archives of General Psychiatry, 47, 754758.
Van Rossum, J. M. (1966) The significance of dopamine receptor blockade in the mechanism of action of neuroleptic drugs. Archives of International Pharmacodynamics and Therapeutics, 60, 492494.
Waddington, J. L. (1989) Implications of recent research on dopamine D-1 and D-2 receptor subtypes in relation to schizophrenia and neuroleptic drug action. Current Opinion in Psychiatry, 2, 8992.
Williams, J. M. G. (1991) Personality disorder and the will: a cognitive neuropsychological approach. Brain and Behavioural Sciences (submitted).
Wong, D. F., Wagner, H. N., Tune, L. E., et al (1986) Positron emission tomography reveals elevated D-2 dopamine receptors in drug-naive schizophrenics. Science, 234, 15581563.

D1 and D2 and D3

  • D. Healy (a1)


Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed

D1 and D2 and D3

  • D. Healy (a1)
Submit a response


No eLetters have been published for this article.


Reply to: Submit a response

Your details

Conflicting interests

Do you have any conflicting interests? *